{"id":689607,"date":"2022-09-28T07:04:10","date_gmt":"2022-09-28T11:04:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/"},"modified":"2022-09-28T07:04:10","modified_gmt":"2022-09-28T11:04:10","slug":"tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/","title":{"rendered":"Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan"},"content":{"rendered":"<div class=\"mw_release\">\n<ul type=\"disc\">\n<li>\u201c<strong>Effect of nasal anti-CD3 (foralumab) in animal model of Progressive Multiple Sclerosis (MS)\u201d poster exhibit<\/strong><\/li>\n<li>\u201c<strong>Effect of nasal anti-CD3 (foralumab) in healthy subjects\u201d poster exhibit<\/strong><\/li>\n<li>\u201c<strong>Effect of nasal anti-CD3 (foralumab) in patient with Progressive MS\u201d poster exhibit<\/strong><\/li>\n<li>\n          <strong>Howard L. Weiner, M.D. of Brigham and Women\u2019s Hospital (BWH) and Tiziana Scientific Advisory Board Chairman, interviewed first patient to receive internasal foralumab for Secondary Progressive MS (SPMS)<\/strong>\n        <\/li>\n<\/ul>\n<p>NEW YORK, Sept.  28, 2022  (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (\u201cTiziana\u201d or the \u201cCompany\u201d), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that poster presentations on intranasal foralumab were presented at the \u201cPreserving the Brain\u201d scientific conference and exhibit held at the Fondazione Prada in Milan, Italy. In addition, the first Secondary Progressive Multiple Sclerosis (SPMS) patient receiving intranasal foralumab was interviewed by Dr. Howard L. Weiner of Brigham and Women\u2019s Hospital, who is also the Chairman of Tiziana\u2019s Scientific Advisory Board.<\/p>\n<p>\u201cPreserving the Brain\u201d is a scientific forum and exhibit on neurodegenerative diseases as part of the \u201cHuman Brains\u201d neuroscience project held in Fondazione Prada in Milan, Italy. The aim of this event is to stimulate an open and critical exchange between international scientists and experts on neurodegenerative diseases.<\/p>\n<p>At the \u201cTranslation of Scientific Discovery to Patient Care\u201d workshop, Howard L. Weiner, M.D., Co-Director of the\u00a0Ann Romney Center for Neurologic Diseases\u00a0at BWH and Chairman of Tiziana\u2019s\u00a0Scientific Advisory Board interviewed the first patient to receive intranasal foralumab for Progressive MS. In addition, posters on the effect of nasal anti-CD3 (foralumab) were presented.<\/p>\n<p>\u201cI am absolutely thrilled that foralumab was highlighted at the Fondazione Prada\u2019s \u201cPreserving the Brain\u201d international forum,\u201d commented Gabriele Cerrone, Executive Chairman and interim Chief Executive Officer of Tiziana Life Sciences. \u201cHaving the first patient to ever receive intranasal foralumab for Secondary Progressive Multiple Sclerosis interviewed at an esteemed cultural institution such as Fondazione Prada only further validates our passion and focus to advance this novel therapy.\u201d\u00a0\u00a0<\/p>\n<p>Dr. Weiner\u2019s patient interview (presented at the conference on 27<sup>th<\/sup> September 2022 at 6pm CEST) can be seen at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZCW-UhXdmS3eBr7hIYwGhQEj6y99W7OyH43q6yLjP-l1iymAU-_K3hjjkUBNCaxAxYn0oiO6t30_MrZrv-hwykMRaaenMY52Gc7HveFYybenWEPMuYLYezZ66wfKNxuAjwuuVtGqz1vioJ-KQdtsj4MtpyutfsyMuo99H6DMc1Qb2mr9ZGyDaNPbP2ZoElu1QglcvktjSwewlGHrtNabGCGSjORb5lj0xIaxNNvw96Q=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/humanbrains.fondazioneprada.org\/en\/preserving-the-brains\/workshops\/<\/a> and the exhibited posters will be made available by the company after the end of the conference.<\/p>\n<p>\n        <strong>About Fondazione Prada and the \u201cPreserving the Brain\u201d Exhibit<\/strong>\n      <\/p>\n<p>The exhibition will be held from 16 September to\u00a010 October 2022\u00a0in the Podium, the space at the center of Fondazione Prada&#8217;s\u00a0Milan\u00a0venue. Conceived by the\u00a0New York\u00a0studio 2&#215;4, the exhibition design will be divided into different sections supervised by the research centers, and a common central area that will encourage dialogue and exchanges between the thirteen institutes. Each section will examine a specific research process on neurodegenerative diseases employing video presentations, technological objects and instruments, scientific documents, and visual materials.<\/p>\n<p>Throughout the opening of the exhibition, the 13 institutions participating in the project will give a series of online workshops that will be available to the public at humanbrains.fondazioneprada.org. Each meeting will enable the assessment of a specific aspect in the search for new treatments for neurodegenerative diseases.<\/p>\n<p>The pivotal moment of &#8220;Preserving the Brain&#8221; will be the scientific conference held on 6 and\u00a07 October 2022, at Fondazione Prada&#8217;s Cinema in\u00a0Milan. The speakers will explore the subject of neurodegenerative diseases from different perspectives, such as genetic implications and molecular mechanisms, clinical trials and possible drug treatments. The conference is addressed to researchers and universities involved in the project and representatives of prominent institutions in the health sector. The sessions will also be streamed and visible to all on the online platform: <strong>humanbrains.fondazioneprada.org.<\/strong><\/p>\n<p>\n        <strong>About Foralumab<\/strong>\n      <\/p>\n<p>Foralumab (formerly NI-0401), the only entirely human anti-CD3 mAb, has shown reduced release of cytokines after IV administration in healthy volunteers and in patients with Crohn&#8217;s disease. In a humanized mouse model (NOD\/SCID IL2\u03b3c-\/-), it was shown that while targeting the T-cell receptor, orally administered foralumab modulates immune responses of the T-cells and enhances regulatory T-cells (Tregs), thereby providing therapeutic benefit in treating inflammatory and autoimmune diseases without the occurrence of potential adverse events usually associated with parenteral mAb therapy. Once a day treatment for 10 consecutive days with intranasal foralumab was both well tolerated and produced clinical responses in COVID-19 patients. Based on these studies, the intranasal and oral administration of Foralumab offers the potential to become a well-tolerated immunotherapy for autoimmune and inflammatory diseases by the induction of Tregs.<\/p>\n<p>\n        <strong>About\u00a0Tiziana Life Sciences<\/strong>\n      <\/p>\n<p>Tiziana Life Sciences\u00a0is a clinical-stage biopharmaceutical company developing breakthrough therapies using transformational drug delivery technologies to enable alternative routes of immunotherapy. Tiziana\u2019s innovative nasal, oral and inhalation approaches in development have the potential to provide an improvement in efficacy as well as safety and tolerability compared to intravenous (IV) delivery. Tiziana\u2019s two lead candidates, intranasal foralumab, the only fully human anti-CD3 mAb, and milciclib, a pan-CDK inhibitor, have both demonstrated a favorable safety profile and clinical response in patients in studies to date. Tiziana\u2019s technology for alternative routes of immunotherapy has been patented with several applications pending and is expected to allow for broad pipeline applications.<\/p>\n<p>For further inquiries:<\/p>\n<p>\n        <strong>Tiziana Life Sciences Ltd<\/strong>\n      <\/p>\n<p>Hana Malik, Business Development and Investor Relations Manager<br \/>+44 (0) 207 495 2379<br \/>email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3YZnWK6p2vTyCK6bYcg--g1vPiK5hVafOQU4IwLGHiHTuF0BJjuHg8fra-bYyIhxnqi5amZ2BACG6Gjqen5lIiXpzWe5QV0_8uGKOVk9OWqLfTDUt5ggV_dtli6sb6jT\" rel=\"nofollow noopener\" target=\"_blank\"><u>info@tizianalifesciences.com<\/u><\/a><\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Irina Koffler<br \/>LifeSci Advisors, LLC<br \/>646.970.4681<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ydv6v4vsvKZxKsSSI_1-2dY_lrzdQ_4LtRpywpQY5G76M5z48lU178s_WMKfdq9cbNRNUFw3r4RUTz8F71ZEUL_ZyFYJV8oRygtVyhJ2FzAd6abKuAnRA5e1BbjqNBw4\" rel=\"nofollow noopener\" target=\"_blank\"><u>ikoffler@lifesciadvisors.com<\/u><\/a><\/p>\n<p>\n        \n      <\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NDgwOCM1MTc1ODcxIzIxMjM4ODU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjhjMmJkNGItMGIwZC00MTA0LTlmZGYtYTQyMTY2MzdiNjAzLTExMzU0NTY=\/tiny\/Tiziana-Life-Sciences-Plc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u201cEffect of nasal anti-CD3 (foralumab) in animal model of Progressive Multiple Sclerosis (MS)\u201d poster exhibit \u201cEffect of nasal anti-CD3 (foralumab) in healthy subjects\u201d poster exhibit \u201cEffect of nasal anti-CD3 (foralumab) in patient with Progressive MS\u201d poster exhibit Howard L. Weiner, M.D. of Brigham and Women\u2019s Hospital (BWH) and Tiziana Scientific Advisory Board Chairman, interviewed first patient to receive internasal foralumab for Secondary Progressive MS (SPMS) NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (\u201cTiziana\u201d or the \u201cCompany\u201d), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that poster presentations on intranasal foralumab were presented at the \u201cPreserving the Brain\u201d scientific conference and exhibit held at the Fondazione Prada &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-689607","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"\u201cEffect of nasal anti-CD3 (foralumab) in animal model of Progressive Multiple Sclerosis (MS)\u201d poster exhibit \u201cEffect of nasal anti-CD3 (foralumab) in healthy subjects\u201d poster exhibit \u201cEffect of nasal anti-CD3 (foralumab) in patient with Progressive MS\u201d poster exhibit Howard L. Weiner, M.D. of Brigham and Women\u2019s Hospital (BWH) and Tiziana Scientific Advisory Board Chairman, interviewed first patient to receive internasal foralumab for Secondary Progressive MS (SPMS) NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (\u201cTiziana\u201d or the \u201cCompany\u201d), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that poster presentations on intranasal foralumab were presented at the \u201cPreserving the Brain\u201d scientific conference and exhibit held at the Fondazione Prada &hellip; Continue reading &quot;Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-28T11:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NDgwOCM1MTc1ODcxIzIxMjM4ODU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan\",\"datePublished\":\"2022-09-28T11:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/\"},\"wordCount\":899,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NDgwOCM1MTc1ODcxIzIxMjM4ODU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/\",\"name\":\"Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NDgwOCM1MTc1ODcxIzIxMjM4ODU=\",\"datePublished\":\"2022-09-28T11:04:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NDgwOCM1MTc1ODcxIzIxMjM4ODU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NDgwOCM1MTc1ODcxIzIxMjM4ODU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/","og_locale":"en_US","og_type":"article","og_title":"Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan - Market Newsdesk","og_description":"\u201cEffect of nasal anti-CD3 (foralumab) in animal model of Progressive Multiple Sclerosis (MS)\u201d poster exhibit \u201cEffect of nasal anti-CD3 (foralumab) in healthy subjects\u201d poster exhibit \u201cEffect of nasal anti-CD3 (foralumab) in patient with Progressive MS\u201d poster exhibit Howard L. Weiner, M.D. of Brigham and Women\u2019s Hospital (BWH) and Tiziana Scientific Advisory Board Chairman, interviewed first patient to receive internasal foralumab for Secondary Progressive MS (SPMS) NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (\u201cTiziana\u201d or the \u201cCompany\u201d), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that poster presentations on intranasal foralumab were presented at the \u201cPreserving the Brain\u201d scientific conference and exhibit held at the Fondazione Prada &hellip; Continue reading \"Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-28T11:04:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NDgwOCM1MTc1ODcxIzIxMjM4ODU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan","datePublished":"2022-09-28T11:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/"},"wordCount":899,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NDgwOCM1MTc1ODcxIzIxMjM4ODU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/","name":"Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NDgwOCM1MTc1ODcxIzIxMjM4ODU=","datePublished":"2022-09-28T11:04:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NDgwOCM1MTc1ODcxIzIxMjM4ODU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NDgwOCM1MTc1ODcxIzIxMjM4ODU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-announces-presentations-on-intranasal-foralumab-at-the-preserving-the-brain-scientific-conference-and-exhibit-at-the-fondazione-prada-in-milan\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the \u201cPreserving the Brain\u201d Scientific Conference and Exhibit at the Fondazione Prada in Milan"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/689607","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=689607"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/689607\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=689607"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=689607"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=689607"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}